Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Hui Zhu et al.|Cancer Research|2022Cited by 106
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancerYunong Xie, Man Tong|Cell Death and Disease|2024Cited by 18
Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0
Supplementary Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0
Supplementary Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular CarcinomaEtienne Ho Kit Mok, Terence K. Lee, Carmen Oi Ning Leung et al.|Unknown|2023Cited by 0